Healthcare provider profile · identity verified

Huiling Ji

Internal Medicine · FALL RIVER, MA · NPI 1962998468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	745	219
Amlodipine Besylate	Amlodipine Besylate	438	133
Rosuvastatin Calcium	Rosuvastatin Calcium	379	105
Levothyroxine Sodium	Levothyroxine Sodium	374	99
Lisinopril	Lisinopril	374	108
Losartan Potassium	Losartan Potassium	370	97
Omeprazole	Omeprazole	286	87
Hydrochlorothiazide	Hydrochlorothiazide	266	76
Gabapentin	Gabapentin	205	59
Metformin Hcl Er	Metformin Hcl	196	54
Tamsulosin Hcl	Tamsulosin Hcl	180	47
Metformin Hcl	Metformin Hcl	167	49
Sertraline Hcl	Sertraline Hcl	146	48
Simvastatin	Simvastatin	139	41
Eliquis	Apixaban	133	22
Metoprolol Succinate	Metoprolol Succinate	124	37
Meloxicam	Meloxicam	123	41
Furosemide	Furosemide	119	28
Albuterol Sulfate Hfa	Albuterol Sulfate	118	32
Pantoprazole Sodium	Pantoprazole Sodium	115	37
Escitalopram Oxalate	Escitalopram Oxalate	113	31
Allopurinol	Allopurinol	105	33
Trazodone Hcl	Trazodone Hcl	100	32
Metoprolol Tartrate	Metoprolol Tartrate	99	26
Atenolol	Atenolol	94	25
Jardiance	Empagliflozin	78	16
Pravastatin Sodium	Pravastatin Sodium	77	25
Fluticasone Propionate	Fluticasone Propionate	76	35
Potassium Chloride	Potassium Chloride	68	17
Famotidine	Famotidine	65	23
Carvedilol	Carvedilol	63	16
Ezetimibe	Ezetimibe	61	18
Montelukast Sodium	Montelukast Sodium	60	18
Citalopram Hbr	Citalopram Hydrobromide	59	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Tramadol Hcl	Tramadol Hcl	54	14
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Ibuprofen	Ibuprofen	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	18
Ventolin Hfa	Albuterol Sulfate	51	13
Clonazepam	Clonazepam	50	12
Duloxetine Hcl	Duloxetine Hcl	50	16
Glipizide Er	Glipizide	43	13
Irbesartan	Irbesartan	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	suppressed
Alprazolam	Alprazolam	39	13
Paroxetine Hcl	Paroxetine Hcl	38	12
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Finasteride	Finasteride	37	suppressed
Glipizide	Glipizide	37	suppressed
Lorazepam	Lorazepam	37	13
Azithromycin	Azithromycin	35	33
Diclofenac Sodium	Diclofenac Sodium	35	17
Donepezil Hcl	Donepezil Hcl	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	29
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Chlorthalidone	Chlorthalidone	32	11
Amitriptyline Hcl	Amitriptyline Hcl	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ozempic	Semaglutide	30	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Valsartan	Valsartan	29	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Verapamil Er	Verapamil Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amoxicillin	Amoxicillin	21	18
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Ofloxacin	Ofloxacin	19	19
Methylprednisolone	Methylprednisolone	18	16
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Colchicine	Colchicine	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Prednisone	Prednisone	14	suppressed
Primidone	Primidone	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Amiloride Hcl	Amiloride Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Risperidone	Risperidone	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error